* Rivaroxaban is an oral direct inhibitor of factor Xa (activated factor X) with a dose-dependent effect on prothrombin time.
* Indications:
. Reducing stroke risk in nonvalvular atrial fibrillation (AF)
. Deep vein thrombosis (DVT) and pulmonary embolism (PE) treatment and reduction in the risk of recurrence
. DVT prophylaxis after knee or hip replacement surgery
Related products
